Skip to main content
Fig. 7 | BMC Psychiatry

Fig. 7

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

Fig. 7

Change in Satisfaction with Current Injectable Medication, Paliperidone Palmitate Group. Gold bars represent patients who were satisfied or very satisfied with their current injectable medication at a given assessment; blue bars indicate patients who were neither satisfied nor dissatisfied, and red bars indicate patients who were dissatisfied or very dissatisfied. Path color indicates patients’ level of satisfaction at the previous MSQ assessment. The width of each bar and path is proportional to the number of patients represented. PP patients who completed MSQ at all 4 timepoints are included; n = 43

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us